申请人:Eli Lilly and Company
公开号:US06384281B1
公开(公告)日:2002-05-07
A pharmaceutical compound of formula (I) in which R1 and R2 are each hydrogen or C1-4 alkyl, or R1 and R2 together with the nitrogen atom to which they are attached form an azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, or morpholino group, said group being optionally substituted with 1 to 3 C1-4alkyl substituents, R3 is a naphythyl, indolyl, benzothienyl, benzofuranyl, benzothiazolyl, quinolinyl or isoquinolinyl group, said group being optionally substituted, and n is 1 or 2; or a salt or ester thereof.
化合物(I)的化学式为:其中R1和R2分别为氢或C1-4烷基,或者R1和R2与它们连接的氮原子形成一个氮杂环,该氮杂环可以是氮杂环丙烷基、吡咯烷基、哌啶基、哌嗪基或吗啉基,该基团可以选填有1到3个C1-4烷基取代基;R3为萘基、吲哚基、苯并噻吩基、苯并呋喃基、苯并噻唑基、喹啉基或异喹啉基,该基团可以选填取代基;n为1或2;或其盐或酯。